Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 0.71% | 579.81 | 2.7% | $671.17m | |
| AMGN | Amgen, Inc. | -0.36% | 227.16 | 1.3% | $582.50m | |
| GILD | Gilead Sciences, Inc. | 0.20% | 60.79 | 1.0% | $581.98m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.71% | 211.58 | 1.9% | $512.07m | |
| ILMN | Illumina, Inc. | -0.73% | 323.55 | 3.5% | $494.75m | |
| MRNA | Moderna, Inc. | -0.44% | 70.53 | 0.0% | $473.04m | |
| ARRY | Array BioPharma Inc. | -4.42% | 42.00 | 14.2% | $403.84m | |
| IMMU | Immunomedics, Inc. | 0.00% | 87.86 | 11.0% | $392.45m | |
| NVAX | Novavax, Inc. | -0.49% | 93.13 | 96.5% | $309.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.62% | 121.61 | 2.0% | $277.29m | |
| BIIB | Biogen, Inc. | -0.68% | 265.00 | 1.7% | $264.24m | |
| EXAS | EXACT Sciences Corp. | 2.44% | 109.70 | 20.7% | $241.86m | |
| BNTX | BioNTech SE | 2.70% | 88.69 | 0.0% | $221.27m | |
| SRNE | Sorrento Therapeutics, Inc. | -2.42% | 8.08 | 1.4% | $162.95m | |
| SGEN | Seagen Inc. | -1.86% | 196.92 | 6.0% | $157.61m |
Company Profile
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded on December 18, 2013 and is headquartered in Norwood, MA.